Planned sale of 19,500 shares in KTOS (NASDAQ: KTOS) filing disclosure
Rhea-AI Filing Summary
An affiliate of KTOS filed a Form 144 indicating an intent to sell up to 19,500 shares of common stock through Morgan Stanley Smith Barney, with an indicated aggregate market value of $2,369,250.00. The filing notes that 168,840,708 shares of the issuer’s common stock were outstanding and lists an approximate sale date of 01/15/2026 on the NASDAQ.
The shares to be sold were acquired from the issuer as 13,000 restricted stock units on 01/04/2024 and 6,500 performance stock units on 02/28/2025. The notice also reports that during the past three months there were 10b5-1 sales for Phillip Carrai of 6,000 common shares on 12/15/2025, generating $455,451.18 in gross proceeds.
Positive
- None.
Negative
- None.
FAQ
What does the KTOS Form 144 filing disclose?
The Form 144 for KTOS discloses a planned sale of up to 19,500 shares of common stock, with an indicated aggregate market value of $2,369,250.00, to be executed through Morgan Stanley Smith Barney on the NASDAQ.
Which broker is handling the planned KTOS Form 144 sale?
The planned sale of 19,500 KTOS common shares is listed as being handled by Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004, with trading on the NASDAQ exchange.
Does the KTOS Form 144 reference Rule 10b5-1 trading activity?
Yes. The section on securities sold during the past three months describes "10b5-1 Sales for PHILLIP CARRAI", reporting a sale of 6,000 common shares on 12/15/2025 for $455,451.18 in gross proceeds.